Published in J Bone Miner Res on August 03, 2010
Pharmacological inhibition of PHOSPHO1 suppresses vascular smooth muscle cell calcification. J Bone Miner Res (2013) 1.60
The role of phosphatases in the initiation of skeletal mineralization. Calcif Tissue Int (2012) 1.26
Inflammatory, metabolic, and genetic mechanisms of vascular calcification. Arterioscler Thromb Vasc Biol (2014) 1.21
PHOSPHO1 is essential for mechanically competent mineralization and the avoidance of spontaneous fractures. Bone (2011) 1.12
Osteocyte regulation of bone mineral: a little give and take. Osteoporos Int (2012) 1.11
Tooth root dentin mineralization defects in a mouse model of hypophosphatasia. J Bone Miner Res (2013) 1.09
Calcium phosphate-bearing matrices induce osteogenic differentiation of stem cells through adenosine signaling. Proc Natl Acad Sci U S A (2014) 1.08
Calcium and bone disease. Biofactors (2011) 1.02
MEPE is a novel regulator of growth plate cartilage mineralization. Bone (2012) 1.01
In vivo overexpression of tissue-nonspecific alkaline phosphatase increases skeletal mineralization and affects the phosphorylation status of osteopontin. J Bone Miner Res (2013) 0.97
Entpd5 is essential for skeletal mineralization and regulates phosphate homeostasis in zebrafish. Proc Natl Acad Sci U S A (2012) 0.91
Compounded PHOSPHO1/ALPL deficiencies reduce dentin mineralization. J Dent Res (2013) 0.90
Hypophosphatasia - pathophysiology and treatment. Actual osteol (2012) 0.90
Hypophosphatasia - aetiology, nosology, pathogenesis, diagnosis and treatment. Nat Rev Endocrinol (2016) 0.89
Reference point indentation is not indicative of whole mouse bone measures of stress intensity fracture toughness. Bone (2014) 0.89
Rescue of severe infantile hypophosphatasia mice by AAV-mediated sustained expression of soluble alkaline phosphatase. Hum Gene Ther (2011) 0.88
Counter-regulatory phosphatases TNAP and NPP1 temporally regulate tooth root cementogenesis. Int J Oral Sci (2015) 0.88
Putative function of TAP63α during endochondral bone formation. Gene (2012) 0.85
Choline kinase beta is required for normal endochondral bone formation. Biochim Biophys Acta (2014) 0.84
Ablation of osteopontin improves the skeletal phenotype of phospho1(-/-) mice. J Bone Miner Res (2014) 0.84
Identification of novel regulators of osteoblast matrix mineralization by time series transcriptional profiling. J Bone Miner Metab (2013) 0.84
Alkaline Phosphatase and Hypophosphatasia. Calcif Tissue Int (2015) 0.83
Dual role of the Trps1 transcription factor in dentin mineralization. J Biol Chem (2014) 0.83
Association of Serum Phosphate and Related Factors in ESRD-Related Vascular Calcification. Int J Nephrol (2011) 0.82
Extracellular matrix mineralization in periodontal tissues: Noncollagenous matrix proteins, enzymes, and relationship to hypophosphatasia and X-linked hypophosphatemia. Periodontol 2000 (2013) 0.82
The Functional co-operativity of Tissue-Nonspecific Alkaline Phosphatase (TNAP) and PHOSPHO1 during initiation of Skeletal Mineralization. Biochem Biophys Rep (2015) 0.81
An investigation of the mineral in ductile and brittle cortical mouse bone. J Bone Miner Res (2015) 0.80
Choline kinase β mutant mice exhibit reduced phosphocholine, elevated osteoclast activity, and low bone mass. J Biol Chem (2014) 0.80
Phosphate/pyrophosphate and MV-related proteins in mineralisation: discoveries from mouse models. Int J Biol Sci (2012) 0.77
Zooming in on the genesis of atherosclerotic plaque microcalcifications. J Physiol (2016) 0.77
Presence of matrix vesicles in the body of odontoblasts and in the inner third of dentinal tissue: a scanning electron microscopic study. Med Oral Patol Oral Cir Bucal (2013) 0.77
Haploinsufficiency for either one of the type-II regulatory subunits of protein kinase A improves the bone phenotype of Prkar1a+/- mice. Hum Mol Genet (2015) 0.76
Skeletal Mineralization Deficits and Impaired Biogenesis and Function of Chondrocyte-Derived Matrix Vesicles in Phospho1(-/-) and Phospho1/Pi t1 Double-Knockout Mice. J Bone Miner Res (2016) 0.76
Specification of osteoblast cell fate by canonical Wnt signaling requires Bmp2. Development (2016) 0.75
Pth4, an ancient parathyroid hormone lost in eutherian mammals, reveals a new brain-to-bone signaling pathway. FASEB J (2016) 0.75
Micro CT Analysis of Spine Architecture in a Mouse Model of Scoliosis. Front Endocrinol (Lausanne) (2015) 0.75
Proteoliposomes with the ability to transport Ca(2+) into the vesicles and hydrolyze phosphosubstrates on their surface. Arch Biochem Biophys (2015) 0.75
The Expression of PHOSPHO1, nSMase2 and TNAP is Coordinately Regulated by Continuous PTH Exposure in Mineralising Osteoblast Cultures. Calcif Tissue Int (2016) 0.75
Pathophysiology of hypophosphatasia and the potential role of asfotase alfa. Ther Clin Risk Manag (2016) 0.75
Role of PHOSPHO1 in Periodontal Development and Function. J Dent Res (2016) 0.75
Phosphate induces formation of matrix vesicles during odontoblast-initiated mineralization in vitro. Matrix Biol (2016) 0.75
Effects of etidronate on the Enpp1⁻/⁻ mouse model of generalized arterial calcification of infancy. Int J Mol Med (2015) 0.75
Imaging and mapping of mouse bone using MALDI-imaging mass spectrometry. Bone Rep (2016) 0.75
The Possible Significance of Hexosephosphoric Esters in Ossification. Biochem J (1923) 75.39
Role of the mouse ank gene in control of tissue calcification and arthritis. Science (2000) 4.43
Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization. Proc Natl Acad Sci U S A (2002) 4.22
Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone. Genes Dev (2005) 3.38
Concerted regulation of inorganic pyrophosphate and osteopontin by akp2, enpp1, and ank: an integrated model of the pathogenesis of mineralization disorders. Am J Pathol (2004) 3.15
Vesicles associated with calcification in the matrix of epiphyseal cartilage. J Cell Biol (1969) 2.99
Association of inorganic-pyrophosphatase activity with human alkaline-phosphatase preparations. Biochem J (1967) 2.78
Isolation and characterization of calcifying matrix vesicles from epiphyseal cartilage. Proc Natl Acad Sci U S A (1970) 2.77
Hypophosphatasia and the role of alkaline phosphatase in skeletal mineralization. Endocr Rev (1994) 2.73
Enzyme replacement therapy for murine hypophosphatasia. J Bone Miner Res (2008) 2.64
Alkaline phosphatase knock-out mice recapitulate the metabolic and skeletal defects of infantile hypophosphatasia. J Bone Miner Res (1999) 2.50
Inactivation of two mouse alkaline phosphatase genes and establishment of a model of infantile hypophosphatasia. Dev Dyn (1997) 2.47
Inorganic pyrophosphate generation and disposition in pathophysiology. Am J Physiol Cell Physiol (2001) 2.36
Pyrophosphate inhibits mineralization of osteoblast cultures by binding to mineral, up-regulating osteopontin, and inhibiting alkaline phosphatase activity. J Biol Chem (2007) 2.03
Impaired calcification around matrix vesicles of growth plate and bone in alkaline phosphatase-deficient mice. Am J Pathol (2004) 1.93
Can biological calcification occur in the presence of pyrophosphate? Arch Biochem Biophys (1984) 1.88
Linked deficiencies in extracellular PP(i) and osteopontin mediate pathologic calcification associated with defective PC-1 and ANK expression. J Bone Miner Res (2003) 1.83
The role of matrix vesicles in growth plate development and biomineralization. Front Biosci (2005) 1.70
Functional involvement of PHOSPHO1 in matrix vesicle-mediated skeletal mineralization. J Bone Miner Res (2007) 1.68
Osteoblast tissue-nonspecific alkaline phosphatase antagonizes and regulates PC-1. Am J Physiol Regul Integr Comp Physiol (2000) 1.50
Abnormal vitamin B6 metabolism in alkaline phosphatase knock-out mice causes multiple abnormalities, but not the impaired bone mineralization. J Pathol (2001) 1.48
Studies on matrix vesicles isolated from chick epiphyseal cartilage. Association of pyrophosphatase and ATPase activities with alkaline phosphatase. Biochim Biophys Acta (1975) 1.44
Matrix vesicles in osteomalacic hypophosphatasia bone contain apatite-like mineral crystals. Am J Pathol (1997) 1.41
Elevated skeletal osteopontin levels contribute to the hypophosphatasia phenotype in Akp2(-/-) mice. J Bone Miner Res (2006) 1.39
Enhanced expression of the inorganic phosphate transporter Pit-1 is involved in BMP-2-induced matrix mineralization in osteoblast-like cells. J Bone Miner Res (2006) 1.33
Kinetic analysis of substrate utilization by native and TNAP-, NPP1-, or PHOSPHO1-deficient matrix vesicles. J Bone Miner Res (2010) 1.29
Human PHOSPHO1 exhibits high specific phosphoethanolamine and phosphocholine phosphatase activities. Biochem J (2004) 1.24
Stereospecific inhibition of alkaline phosphatase by L-tetramisole prevents in vitro cartilage calcification. Lab Invest (1980) 1.11
The presence of PHOSPHO1 in matrix vesicles and its developmental expression prior to skeletal mineralization. Bone (2006) 1.09
Hereditary joint disorder in progressive ankylosis (ank/ank) mice. I. Association of calcium hydroxyapatite deposition with inflammatory arthropathy. Arthritis Rheum (1984) 1.06
PHOSPHO1-A novel phosphatase specifically expressed at sites of mineralisation in bone and cartilage. Bone (2004) 1.04
Identification and cloning of a novel phosphatase expressed at high levels in differentiating growth plate chondrocytes. Biochim Biophys Acta (1999) 1.02
Mechanical determinants of bone modeling. Metab Bone Dis Relat Res (1982) 0.99
Changes in phospholipid extractability and composition accompany mineralization of chicken growth plate cartilage matrix vesicles. J Biol Chem (2001) 0.98
Evidence of the presence of a specific ATPase responsible for ATP-initiated calcification by matrix vesicles isolated from cartilage and bone. J Biol Chem (1996) 0.94
Roles of alkaline phosphatase and labile internal mineral in matrix vesicle-mediated calcification. Effect of selective release of membrane-bound alkaline phosphatase and treatment with isosmotic pH 6 buffer. J Biol Chem (1986) 0.93
Comparative modelling of human PHOSPHO1 reveals a new group of phosphatases within the haloacid dehalogenase superfamily. Protein Eng (2003) 0.92
Phosphatidylcholine metabolism in neonatal mouse calvaria. Biochem J (1987) 0.91
31P NMR studies of resting zone cartilage from growth plate. Magn Reson Med (1992) 0.89
Kinetic characterization of a membrane-specific ATPase from rat osseous plate and its possible significance on endochodral ossification. Biochim Biophys Acta (1998) 0.88
Allosteric modulation by ATP, calcium and magnesium ions of rat osseous plate alkaline phosphatase. Biochim Biophys Acta (1993) 0.88
Effects of analogues of inorganic phosphate and sodium ion on mineralization of matrix vesicles isolated from growth plate cartilage of normal rapidly growing chickens. J Inorg Biochem (2003) 0.85
Severe kyphoscoliosis associated with osteomalacia. Spine J (2006) 0.77
Endocrine regulation of energy metabolism by the skeleton. Cell (2007) 10.41
Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res (2007) 6.76
Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization. Proc Natl Acad Sci U S A (2002) 4.22
Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone. Genes Dev (2005) 3.38
Enzyme-replacement therapy in life-threatening hypophosphatasia. N Engl J Med (2012) 3.27
Concerted regulation of inorganic pyrophosphate and osteopontin by akp2, enpp1, and ank: an integrated model of the pathogenesis of mineralization disorders. Am J Pathol (2004) 3.15
Extracellular matrix mineralization is regulated locally; different roles of two gla-containing proteins. J Cell Biol (2004) 2.90
Enzyme replacement therapy for murine hypophosphatasia. J Bone Miner Res (2008) 2.64
Enamel defects and ameloblast-specific expression in Enam knock-out/lacz knock-in mice. J Biol Chem (2008) 2.05
Pyrophosphate inhibits mineralization of osteoblast cultures by binding to mineral, up-regulating osteopontin, and inhibiting alkaline phosphatase activity. J Biol Chem (2007) 2.03
Rescue of odontogenesis in Dmp1-deficient mice by targeted re-expression of DMP1 reveals roles for DMP1 in early odontogenesis and dentin apposition in vivo. Dev Biol (2006) 2.00
Intestinal alkaline phosphatase is a gut mucosal defense factor maintained by enteral nutrition. Proc Natl Acad Sci U S A (2008) 1.97
Impaired calcification around matrix vesicles of growth plate and bone in alkaline phosphatase-deficient mice. Am J Pathol (2004) 1.93
Intestinal alkaline phosphatase prevents metabolic syndrome in mice. Proc Natl Acad Sci U S A (2013) 1.89
Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification. Am J Pathol (2002) 1.88
Germ cell survival through carbohydrate-mediated interaction with Sertoli cells. Science (2002) 1.87
Linked deficiencies in extracellular PP(i) and osteopontin mediate pathologic calcification associated with defective PC-1 and ANK expression. J Bone Miner Res (2003) 1.83
Intermittent injections of osteocalcin improve glucose metabolism and prevent type 2 diabetes in mice. Bone (2011) 1.75
Functional involvement of PHOSPHO1 in matrix vesicle-mediated skeletal mineralization. J Bone Miner Res (2007) 1.68
Inactivation of the osteopontin gene enhances vascular calcification of matrix Gla protein-deficient mice: evidence for osteopontin as an inducible inhibitor of vascular calcification in vivo. J Exp Med (2002) 1.67
Accelerated fat absorption in intestinal alkaline phosphatase knockout mice. Mol Cell Biol (2003) 1.60
Pharmacological inhibition of PHOSPHO1 suppresses vascular smooth muscle cell calcification. J Bone Miner Res (2013) 1.60
Fibrillin assembly requires fibronectin. Mol Biol Cell (2008) 1.53
MEPE-ASARM peptides control extracellular matrix mineralization by binding to hydroxyapatite: an inhibition regulated by PHEX cleavage of ASARM. J Bone Miner Res (2008) 1.52
Proteoglycan desulfation determines the efficiency of chondrocyte autophagy and the extent of FGF signaling during endochondral ossification. Genes Dev (2008) 1.46
Phosphorylation-dependent inhibition of mineralization by osteopontin ASARM peptides is regulated by PHEX cleavage. J Bone Miner Res (2010) 1.45
Total protein analysis as a reliable loading control for quantitative fluorescent Western blotting. PLoS One (2013) 1.43
The biological function of DMP-1 in osteocyte maturation is mediated by its 57-kDa C-terminal fragment. J Bone Miner Res (2011) 1.42
The appearance and modulation of osteocyte marker expression during calcification of vascular smooth muscle cells. PLoS One (2011) 1.40
Renal calcification in mice homozygous for the disrupted type IIa Na/Pi cotransporter gene Npt2. J Bone Miner Res (2003) 1.39
Elevated skeletal osteopontin levels contribute to the hypophosphatasia phenotype in Akp2(-/-) mice. J Bone Miner Res (2006) 1.39
Testis-specific cytochrome c-null mice produce functional sperm but undergo early testicular atrophy. Mol Cell Biol (2002) 1.38
Residues determining the binding specificity of uncompetitive inhibitors to tissue-nonspecific alkaline phosphatase. J Bone Miner Res (2004) 1.36
Partial rescue of the Hyp phenotype by osteoblast-targeted PHEX (phosphate-regulating gene with homologies to endopeptidases on the X chromosome) expression. Mol Endocrinol (2002) 1.32
Kinetic analysis of substrate utilization by native and TNAP-, NPP1-, or PHOSPHO1-deficient matrix vesicles. J Bone Miner Res (2010) 1.29
Drilling and microfracture lead to different bone structure and necrosis during bone-marrow stimulation for cartilage repair. J Orthop Res (2009) 1.29
Smooth muscle cells deficient in osteopontin have enhanced susceptibility to calcification in vitro. Cardiovasc Res (2005) 1.28
On the coupling between the incus and the stapes in the cat. J Assoc Res Otolaryngol (2005) 1.28
Regenerative capacity in newts is not altered by repeated regeneration and ageing. Nat Commun (2011) 1.27
Mineral chaperones: a role for fetuin-A and osteopontin in the inhibition and regression of pathologic calcification. J Mol Med (Berl) (2007) 1.26
Extracellular matrix proteins and the dynamics of dentin formation. Connect Tissue Res (2002) 1.26
Aged bovine chondrocytes display a diminished capacity to produce a collagen-rich, mechanically functional cartilage extracellular matrix. J Orthop Res (2005) 1.26
Human PHOSPHO1 exhibits high specific phosphoethanolamine and phosphocholine phosphatase activities. Biochem J (2004) 1.24
Ultrastructural analysis of vascular calcifications in uremia. J Am Soc Nephrol (2010) 1.21
Hand transcription factors cooperatively regulate development of the distal midline mesenchyme. Dev Biol (2007) 1.21
Intestinal alkaline phosphatase has beneficial effects in mouse models of chronic colitis. Inflamm Bowel Dis (2011) 1.18
Altered bone development and an increase in FGF-23 expression in Enpp1(-/-) mice. PLoS One (2012) 1.18
Disruption of the podosome adaptor protein TKS4 (SH3PXD2B) causes the skeletal dysplasia, eye, and cardiac abnormalities of Frank-Ter Haar Syndrome. Am J Hum Genet (2010) 1.18
Disruption of the murine intestinal alkaline phosphatase gene Akp3 impairs lipid transcytosis and induces visceral fat accumulation and hepatic steatosis. Am J Physiol Gastrointest Liver Physiol (2007) 1.17
Central role of pyrophosphate in acellular cementum formation. PLoS One (2012) 1.14
Discovery and validation of a series of aryl sulfonamides as selective inhibitors of tissue-nonspecific alkaline phosphatase (TNAP). J Med Chem (2009) 1.13
Identification and characterization of novel tissue-nonspecific alkaline phosphatase inhibitors with diverse modes of action. J Biomol Screen (2009) 1.12
PHOSPHO1 is essential for mechanically competent mineralization and the avoidance of spontaneous fractures. Bone (2011) 1.12
Severe skeletal toxicity from protracted etidronate therapy for generalized arterial calcification of infancy. J Bone Miner Res (2013) 1.11
Design and synthesis of pyrazole derivatives as potent and selective inhibitors of tissue-nonspecific alkaline phosphatase (TNAP). Bioorg Med Chem Lett (2008) 1.11
Hand2 controls osteoblast differentiation in the branchial arch by inhibiting DNA binding of Runx2. Development (2009) 1.10
A novel phosphatase upregulated in Akp3 knockout mice. Am J Physiol Gastrointest Liver Physiol (2007) 1.09
Enzyme replacement prevents enamel defects in hypophosphatasia mice. J Bone Miner Res (2012) 1.07
Depth of subchondral perforation influences the outcome of bone marrow stimulation cartilage repair. J Orthop Res (2011) 1.07
Elevated expression of hypoxia inducible factor-2alpha in terminally differentiating growth plate chondrocytes. J Cell Physiol (2006) 1.06
Proteolytic processing of osteopontin by PHEX and accumulation of osteopontin fragments in Hyp mouse bone, the murine model of X-linked hypophosphatemia. J Bone Miner Res (2013) 1.06
Inhibition of PHOSPHO1 activity results in impaired skeletal mineralization during limb development of the chick. Bone (2010) 1.06
Cloning of ovocalyxin-36, a novel chicken eggshell protein related to lipopolysaccharide-binding proteins, bactericidal permeability-increasing proteins, and plunc family proteins. J Biol Chem (2006) 1.06
Extracellular pyrophosphate metabolism and calcification in vascular smooth muscle. Am J Physiol Heart Circ Physiol (2011) 1.05
Molecular determinants of extracellular matrix mineralization in bone and blood vessels. Curr Opin Nephrol Hypertens (2010) 1.05
Tissue transglutaminase and its substrates in bone. J Bone Miner Res (2002) 1.05
Osteopontin upregulation and polymerization by transglutaminase 2 in calcified arteries of Matrix Gla protein-deficient mice. J Histochem Cytochem (2006) 1.04
PHOSPHO1-A novel phosphatase specifically expressed at sites of mineralisation in bone and cartilage. Bone (2004) 1.04
Inorganic pyrophosphatase induces type I collagen in osteoblasts. Bone (2009) 1.04
Dose response of bone-targeted enzyme replacement for murine hypophosphatasia. Bone (2011) 1.04
The eggshell: structure, composition and mineralization. Front Biosci (Landmark Ed) (2012) 1.03
A cell-autonomous requirement for neutral sphingomyelinase 2 in bone mineralization. J Cell Biol (2011) 1.02
Mechanisms and clinical consequences of vascular calcification. Front Endocrinol (Lausanne) (2012) 1.01
Absence of alphavbeta6 integrin is linked to initiation and progression of periodontal disease. Am J Pathol (2008) 1.01
Function assignment to conserved residues in mammalian alkaline phosphatases. J Biol Chem (2002) 1.00
The importance of the SIBLING family of proteins on skeletal mineralisation and bone remodelling. J Endocrinol (2012) 1.00